Guillain-Barré Syndrome Linked to the RSV Vaccine

Guillain-Barré Syndrome Linked to the RSV Vaccine

The potential risk of Guillain-Barré syndrome (GBS) developing after receipt of Pfizer’s respiratory experimental syncytial virus (RSV) vaccine have prompted the U.S. Food and Drug Administration (FDA) to request that Pfizer conduct a post-marketing safety study if the vaccine is approved for use in the United States this spring.1 The RSV vaccine manufactured by GlaxoSmithKline […]

More Than 1,000 Adverse Reactions to COVID Shots Reported in New Brunswick, Canada

More Than 1,000 Adverse Reactions to COVID Shots Reported in New Brunswick, Canada

According to the Department of Health in New Brunswick, Canada, 1,148 people living in that province suffered an adverse reaction after receiving a COVID-19 shot between Dec. 14, 2020 and Jan. 14, 2023. It was reported that 313 of the reactions were considered “serious.”1 Health Canada, the department of the Canadian government responsible for national health […]

CDC, FDA Find Possible Link Between Pfizer’s Bivalent COVID Shot and Strokes

CDC, FDA Find Possible Link Between Pfizer’s Bivalent COVID Shot and Strokes

The U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) said last week that they are investigating a possible link between Pfizer/BioNTech’s bivalent messenger RNA (mRNA) Comirnaty COVID biologic and an increased risk of a type of ischemic stroke among people 65 years of age and older. Data from the […]

Another Study Confirms COVID Vaccine Alters Menstrual Cycles

Another Study Confirms COVID Vaccine Alters Menstrual Cycles

A study published in the BMJ Medicine in August 2022 involving almost 20,000 women found an association between those who received a COVID-19 shot and an increased length in menstrual cycles. Of the 15,000 vaccinated women in the study, two-thirds received Pfizer/BioNTech’s COVID messenger RNA (mRNA) biologic, but the data also included women who received […]

South Africa Confirms Second Guillain-Barré Syndrome Death Due to COVID Vaccine

South Africa Confirms Second Guillain-Barré Syndrome Death Due to COVID Vaccine

The South African Health Products Regulatory Authority (SAHPRA) confirmed on Sept. 12, 2022 that another person in South Africa has died of a polio-like neurological disorder that causes paralysis known as Guillain-Barré syndrome (GBS) due to receiving Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S COVID-19 vaccine. SAHPRA said the National Immunization Safety Expert Committee (NISEC) performed […]

German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions

German Report Reveals 1 in 25 Insured Individuals Treated for COVID Shot Reactions

Techniker Krankenkasse, Germany’s largest health insurance company, reported that 437,593 of 11 million (1 in 25) insured individuals in 2021 had to undergo medical treatment as a result of adverse reactions from COVID-19 shots.1 COVID shots currently approved for use in Germany include Novavax’s Nuvaxovid, Moderna’s Spikevax, Pfizer/BioNTech’s Comirnaty, Johnson & Johnson/Janssen’s Ad26.COV2.S, AstraZeneca/Oxford University’s […]

Death in South Africa Causally Linked to Johnson & Johnson COVID Vaccine

Death in South Africa Causally Linked to Johnson & Johnson COVID Vaccine

On Aug. 4, 2022, the South African Health Products Regulatory Authority (SAHPRA) reported the death of an individual in South Africa shortly after receiving Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S COVID-19 vaccine. The agency stated that the death was causally linked to the vaccine.1 2 3 4 5 The name and age of the person […]

FDA Grants EUA for Novavax’s COVID Vaccine

FDA Grants EUA for Novavax’s COVID Vaccine

Opinion | On July 13, 2022, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Novavax to distribute its experimental two-dose NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine for use by adults. The decision was expected, given the favorable recommendation by the FDA’s Vaccines and Related Biological Products Advisory […]

FDA Panel Recommends EUA for Novavax COVID-19 Vaccine

FDA Panel Recommends EUA for Novavax COVID-19 Vaccine

Despite concerns about the risk of developing myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining of the heart) following vaccination with Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted on June 6, […]

Guillain-Barré Syndrome Linked to COVID-19 Shots

Guillain-Barré Syndrome Linked to COVID-19 Shots

A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]

1 2 3